Table 1.
Baseline characteristics
| Parameter | Number of participants (n = 66) |
| Mean age (yr) | 53.3 ± 13.6 |
| Sex | |
| Male | 55 |
| Female | 11 |
| Maximum tumor diameter (cm) | |
| ≤ 5 | 27 |
| 5-10 | 26 |
| > 10 | 13 |
| Child-Pugh score | |
| A | 57 |
| B7 | 9 |
| BCLC stage | |
| B | 29 |
| C | 37 |
| ECOG PS | |
| 0 | 46 |
| 1 | 20 |
| Vascular invasion | |
| Present | 25 |
| Absent | 41 |
| Portal vein invasion | |
| Present | 23 |
| Absent | 43 |
| Extrahepatic metastasis | |
| Present | 16 |
| Absent | 50 |
| HBV | |
| Positive | 54 |
| Negative | 12 |
| HBV DNA (copies/mL) | |
| > 2 × 103 | 30 |
| ≤ 2 × 103 | 36 |
| Cirrhosis | |
| Present | 50 |
| Absent | 16 |
| AFP (ng/mL) | |
| ≤ 100 | 26 |
| > 100 | 40 |
AFP: Alpha-fetoprotein; HBV: Hepatitis B virus infection; BCLC: Barcelona Clinic Liver Cancer; ECOG PS: Eastern Cooperative Oncology Group performance status.